Adma Biologics, Inc. financial data

Symbol
ADMA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
C/O Adma Biologics, Inc., 465 State Route 17, Ramsey, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
R&R ACQUISITION VI, INC (to 2/21/2012)
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 622 % -0.15%
Quick Ratio 354 % -8.93%
Debt-to-equity 74.1 % -45.2%
Return On Equity 85.7 %
Return On Assets 49.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 238M shares +2.51%
Common Stock, Shares, Outstanding 237M shares +4.67%
Entity Public Float 2.54B USD +219%
Common Stock, Value, Issued 24K USD +4.35%
Weighted Average Number of Shares Outstanding, Basic 233M shares +4.07%
Weighted Average Number of Shares Outstanding, Diluted 243M shares +8.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 426M USD +65.2%
Cost of Revenue 207M USD +22.2%
Research and Development Expense 1.81M USD -45.1%
Operating Income (Loss) 139M USD +542%
Nonoperating Income (Expense) -13.3M USD +73.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 126M USD
Income Tax Expense (Benefit) -72M USD
Net Income (Loss) Attributable to Parent 198M USD
Earnings Per Share, Basic 0.85 USD/shares
Earnings Per Share, Diluted 0.81 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103M USD +101%
Accounts Receivable, after Allowance for Credit Loss, Current 50M USD +82.3%
Inventory, Net 170M USD -1.55%
Assets, Current 331M USD +28.9%
Deferred Income Tax Assets, Net 84.3M USD
Property, Plant and Equipment, Net 54.7M USD +1.62%
Operating Lease, Right-of-Use Asset 8.63M USD -10.4%
Intangible Assets, Net (Excluding Goodwill) 460K USD -7.82%
Goodwill 3.53M USD 0%
Assets 489M USD +48.5%
Accounts Payable, Current 20.2M USD +29.1%
Contract with Customer, Liability, Current 143K USD -21.4%
Liabilities, Current 55.5M USD +11.5%
Operating Lease, Liability, Noncurrent 8.56M USD -12.5%
Other Liabilities, Noncurrent 360K USD -14.1%
Liabilities 140M USD -28%
Retained Earnings (Accumulated Deficit) -309M USD +39%
Stockholders' Equity Attributable to Parent 349M USD +158%
Liabilities and Equity 489M USD +48.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.22M USD +84.9%
Net Cash Provided by (Used in) Financing Activities -1.45M USD -123%
Net Cash Provided by (Used in) Investing Activities -2.36M USD -21.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 237M shares +4.67%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.03M USD +65.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 103M USD +101%
Interest Paid, Excluding Capitalized Interest, Operating Activities 584K USD -87.4%
Deferred Tax Assets, Valuation Allowance 0 USD -100%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 94M USD -15.1%
Payments to Acquire Property, Plant, and Equipment 2.35M USD +20.7%
Lessee, Operating Lease, Liability, to be Paid 14.9M USD -13.9%
Property, Plant and Equipment, Gross 88.3M USD +9.54%
Operating Lease, Liability, Current 1.22M USD +16.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.16M USD -10.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.42M USD +1%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.08M USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.04M USD -5.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09M USD +2.3%
Operating Lease, Payments 2.4M USD 0%
Additional Paid in Capital 658M USD +2.52%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 388K USD -46.4%
Depreciation, Depletion and Amortization 7.7M USD +1.32%
Deferred Tax Assets, Net of Valuation Allowance 94M USD +913%
Interest Expense 22.7M USD +3.07%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%